Survey Administered to Physicians Before and After Educational Initiative
| Survey Question | Survey Response | Correct response Before Intervention (n = 36) (n [%]) | Correct response After Intervention (n = 38) (n [%]) | P |
|---|---|---|---|---|
| 1. Which pregnancy drug category are ACE-I and ARB in? | a. A | 15 (41.7) | 22 (57.9) | .176 |
| b. B | ||||
| c. C* | ||||
| d. D* | ||||
| e. X | ||||
| f. I don’t know | ||||
| 2. Which pregnancy drug category is statin in? | a. A | 10 (27.8) | 19 (50) | <.065 |
| b. B | ||||
| c. C | ||||
| d. D | ||||
| e. X* | ||||
| f. I don’t know | ||||
| 3. ACE-I and ARB primarily affect which fetal system if exposed during the second and third trimester? | a. Lung | 23 (63.9) | 28 (73.7) | .440 |
| b. Cardiovascular | ||||
| c. Renal* | ||||
| d. Nervous | ||||
| e. I am unsure | ||||
| 4. There is increasing evidence that ACE-I/ARB have adverse effects to fetuses exposed during the first trimester. | a. True* | 19 (52.8) | 33 (86.8) | .650 |
| b. False | ||||
| c. I am not sure | ||||
| 5. Statin has been shown to adversely affect fetal development in human studies. | a. True | 7 (19.4) | 9 (23.7) | .652 |
| b. False* | ||||
| c. I am not sure | ||||
| 6. In the past several months have you prescribed an ACE-I, ARB, or statin to any women between the ages of 15 to 45? | a. Yes† | 8 (22.2) | 10 (26.3) | 1.000 |
| b. No | ||||
| c. I’m not sure | ||||
| 7. When prescribing ACE-I, ARB, or statin, do you consider the possibility of the patients becoming pregnant while taking the drug? | a. Yes, always† | 24 (66.7) | 31 (81.6) | .678 |
| b. Usually† | ||||
| c. Sometimes | ||||
| d. No, never | ||||
| 8. If you do consider possible pregnancy when prescribing ACE-I/ARB and statin, do you make an effort to document use of contraception and discussion of possible risks? | a. Yes, always† | 25 (69.4) | 28 (73.7) | .091 |
| b. Usually† | ||||
| c. Sometimes | ||||
| d. No, never | ||||
| e. I don’t consider pregnancy risk when prescribing | ||||
| Physician Demographics | ||||
| 9. Gender | a. Male | 19 (52.85) | 17 (44.7) | .316 |
| b. Female | 17 (47.2) | 21 (55.3) | ||
| 10. Current year of residency training | a. PGY-1 | 16 (44.4) | 18 (47.4) | .889 |
| b. PGY-2 | 11 (30.6) | 10 (26.3) | ||
| c. PGY-3 | 8 (22.2) | 9 (23.7) | ||
| d. PGY-4 | 2 (5.6) | 1 (2.6) | ||
| 11. Current residency training program | a. FM | 13 (36.1) | 12 (31.6) | .770 |
| b. IM | 5 (13.9) | 8 (21.1) | ||
| c. FM/IM | 5 (13.9) | 3 (7.9) | ||
| d. OB/GYN | 9 (25.0) | 8 (21.1) | ||
| e. Transitional | 3 (8.3) | 7 (18.4) |